Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Adenocarcinoma Of Esophagus 1

Interventions

Oxaliplatin 2Fluorouracil 2tremelimumab 1pembrolizumab 1monalizumab 1epacadostat 1durvalumab 1Surgical Procedures, Operative 1Nivolumab 1Metabolic Networks and Pathways 1Leucovorin 1Immune Checkpoint Inhibitors 1Fecal Microbiota Transplantation 1Biopsy 1AMG 337 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Adenocarcinoma Of Esophagus × Fecal Microbiota Transplantation × Clear all
NCT05001360 2021-10-27

Study of FMT Combined With Nivolumab in Gastric Cancer

Fujian Cancer Hospital

Phase NA Withdrawn
Gastrointestinal

Adenocarcinoma Of Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡